0001628280-24-029949.txt : 20240625
0001628280-24-029949.hdr.sgml : 20240625
20240625182229
ACCESSION NUMBER: 0001628280-24-029949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blanks Robert
CENTRAL INDEX KEY: 0001815433
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 241070179
MAIL ADDRESS:
STREET 1: C/O ARDELYX
STREET 2: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
wk-form4_1719354142.xml
FORM 4
X0508
4
2024-06-21
0
0001437402
ARDELYX, INC.
ARDX
0001815433
Blanks Robert
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
0
1
0
0
See Remarks
1
Common Stock
2024-06-21
4
S
0
38000
5.955
D
324331
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2023.
Transaction was executed in multiple trades in prices ranging from $5.91 to $6.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Chief Regulatory and Quality Affairs Officer
/s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks
2024-06-25